Corrado Gallo‐Stampino

Synergistic Antitumor Activity of Cisplatin, Paclitaxel, and Gemcitabine with Tumor Vasculature-Targeted Tumor Necrosis Factor-α

Angelina Sacchi, Anna Maria Gasparri, Corrado Gallo‐Stampino et al. · Clinical Cancer Research · 2006 · 145 citations

Medicine, Oncology, Pharmacology +16

Enhanced Expression of CD13 in Vessels of Inflammatory and Neoplastic Tissues

Paola Di Matteo, Gian Luigi Arrigoni, Luca Alberici et al. · Journal of Histochemistry & Cytochemistry · 2011 · 78 citations

Medicine, Oncology, Pathology +16

Clinical and immunologic responses in melanoma patients vaccinated with MAGE‐A3‐genetically modified lymphocytes

Vincenzo Russo, Lorenzo Pilla, Francesca Lunghi et al. · International Journal of Cancer · 2012 · 20 citations · Full text

Medicine, Immunology, Oncology +17

Phase I study of PF-03446962, a fully human mab against ALK 1, a TGFβ receptor involved in tumor angiogenesis.

Laura W. Goff, Filippo de Braud, Richard B. Cohen et al. · Journal of Clinical Oncology · 2010 · 13 citations

Medicine, Oncology, Pharmacology +17

Evaluation of ALK-1 expression in circulating endothelial cells (CECs) as an exploratory biomarker for PF-03446962 undergoing phase I trial in cancer patients

Patrizia Mancuso, David R. Shalinsky, Angelica Calleri et al. · Journal of Clinical Oncology · 2009 · 11 citations

Medicine, Oncology, Pharmacology +17